ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
13,411,190
Share change
-875,849
Total reported value
$30,483,576
Put/Call ratio
82%
Price per share
$2.27
Number of holders
81
Value change
-$3,131,572
Number of buys
36
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q4 2021

As of 31 Dec 2021, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,411,190 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Quantum Private Wealth, LLC, MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, and ACT CAPITAL MANAGEMENT, LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.